Skip to main content
. 2012 Oct 11;22(2):274–281. doi: 10.1007/s00586-012-2536-0

Table 4.

Unhealed lesions at the end of chemotherapy in the two groups

Reasons for poor efficacy Ultra-short-course chemotherapy group (cases) Standard chemotherapy group (cases) x2 P
Multidrug-resistant TB 3 2
Other parts of TB 3 1
Severe liver and renal dysfunction 0 2
Diabetes 1 1
Rheumatic disease 1 0
Total 8 6 5.101 0.021